LEO Laboratories is recalling all remaining stock of Sodium Fusidate 500mg for intravenous infusion from selected batches because of contamination with glass particles in a small number of vials, the MHRA has said.
Particles observed to date have been too large to pass through any needle used for administration of this product but the manufacturer says there is a potential risk of smaller particles being present.
The cause of this problem has been identified and corrected, and the company is expecting replacement stock to be available this month.
Introducing Nursing Times Learning
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Click on the topics below to get started: